Latest Breaking News On - Renhong tang - Page 2 : comparemela.com

DGAP-News: Vivoryon Therapeutics N V : Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application for Varoglutamstat (SIM0408, PQ912) in Patients with Alzheimer s Disease

DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Miscellaneous Vivoryon Therapeutics N.V.: Vivoryon Therapeutics and Simcere Announce CDE Approval of Chinese Clinical Trial Application

Noord hollandRenhong tangJason baoHalle saaleSophia hergenhanManuela baderJian houMichael schaefferSimcere pharmaceutical groupDrug administrationTrophic communicationsSimcere pharmaceutical group ltdDistribution servicesNational medical products administrationNews serviceChina center

Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

/PRNewswire/ Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study.

United statesHong kongRenhong tangJinsheng renWang yongjunMike gresserLauren beaneyThomas zindrickPrnewswire simcere pharmaceutical groupChina national medical products administrationAeromics incSimcere pharmaceutical groupCapital medical universityPharmaceutical groupBeijing tiantanProfessor wang yongjun

Aeromics and Simcere Announce the First-In-Human Dosing of Chinese Healthy Volunteers in Simcere s Phase I Study of The SIM0307 (AER-271), A New Drug for Brain Edema

/PRNewswire/ Simcere Pharmaceutical Group and Aeromics, Inc. today announced that Simcere dosed the first subjects in the SIM0307 (AER-271) Phase I study.

United statesHong kongRenhong tangJinsheng renWang yongjunMike gresserLauren beaneyThomas zindrickPrnewswire simcere pharmaceutical groupChina national medical products administrationAeromics incSimcere pharmaceutical groupCapital medical universityPharmaceutical groupBeijing tiantanProfessor wang yongjun

Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company

Kazia Licenses Rights to Paxalisib in Greater China to Simcere, a Leading Chinese Pharmaceutical Company
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesHong kongNew south walesSan franciscoRenhong tangPrnewswire kazia therapeutics limitedSimcere pharmaceutical groupSimcere pharmaceutical group ltdGlioblast pty ltdKazia therapeutics limitedHong kong stock exchangeKazia therapeuticsTherapeutics limitedGreater chinaMainland china